Cannabis oil extracts for chronic pain: what else can be learned from another structured prospective cohort?

For example, the UK Medical Cannabis Registry of patients who received full-spectrum cannabis oil extracts found a similar magnitude of reduction in the visual analogue scale, from 6.3 ± 1.7 to 5.4 ± 2.5 at 6 months, but failed to reach statistical significance most likely because of the small number of patients (n = 12) who reached that time point. 19 In another cohort of 206 patients who were treated mostly by full-spectrum inflorescence (but some by oil extracts), average pain severity score dropped from 7.50 (95% confidence interval [CI], 6.75-7.75) t

also in 6,035 other papers